Table I.
Summary of cohort characteristics stratified by COP-MPV.
Variable | COP-MPV 0a | COP-MPV 1a | COP-MPV 2a | P-value |
---|---|---|---|---|
Age (years) | 66.48 | 63.23 | 64.048 | 0.6027 |
Sex | ||||
Male | 20 | 43 | 13 | 0.6444 |
Female | 7 | 22 | 8 | |
BMI (kg/m2) | 24.89 | 26.50 | 28.76 | 0.0655 |
History of alcohol use | ||||
Yes | 12 | 33 | 12 | 0.6810 |
No | 15 | 32 | 9 | |
History of smoking | ||||
Yes | 13 | 31 | 12 | 0.7426 |
No | 14 | 34 | 9 | |
ECOG score | ||||
0 | 16 | 50 | 16 | 0.3801 |
1 | 9 | 14 | 4 | |
2 | 2 | 1 | 1 | |
Tumor primary location | ||||
Nasopharynx | 0 | 1 | 0 | 0.2692 |
Oropharynx | 5 | 13 | 2 | |
Oral cavity | 8 | 29 | 15 | |
Larynx | 4 | 6 | 0 | |
Salivary gland | 3 | 7 | 2 | |
Paranasal sinus | 2 | 5 | 0 | |
Cervical lymph node or unknown primary | 2 | 1 | ||
Cutaneous | 3 | 3 | 0 | |
Tumor histology | ||||
Adenocarcinoma | 1 | 5 | 0 | 0.6290 |
Squamous cell carcinoma | 21 | 52 | 20 | |
Adenoid cystic carcinoma | 1 | 1 | 0 | |
Mucoepidermoid carcinoma | 1 | 1 | 0 | |
Basal cell carcinoma | 1 | 0 | 0 | |
Other | 2 | 6 | 1 | |
Tumor differentiation | ||||
Unable to assess | 7 | 5 | 4 | 0.0617 |
Well differentiated | 7 | 10 | 3 | |
Moderate differentiation | 11 | 29 | 10 | |
Poor differentiation | 2 | 21 | 4 | |
Staging pT | ||||
pT0 | 2 | 2 | 2 | 0.6384 |
pT1 | 10 | 25 | 9 | |
pT2 | 11 | 19 | 6 | |
pT3 | 3 | 11 | 1 | |
pT4 | 1 | 8 | 3 | |
Staging pN | ||||
pN0 | 19 | 41 | 16 | 0.8009 |
pN1 | 3 | 10 | 2 | |
pN2 | 3 | 7 | 3 | |
pN3 | 2 | 6 | 0 | |
Adjuvant radiotherapy | ||||
Yes | 12 | 27 | 4 | 0.1339 |
No | 15 | 38 | 17 | |
Adjuvant chemoradiotherapy | ||||
Yes | 6 | 14 | 2 | 0.4420 |
No | 21 | 51 | 19 | |
Surgical margin status | ||||
Positive | 3 | 9 | 3 | 0.9292 |
Negative | 24 | 56 | 18 | |
WBC (109/l) | 6.51 | 7.56 | 9.16 | 0.0036b |
Hemoglobin (g/dl) | 13.39 | 13.30 | 6.81 | 0.1356 |
MPV (fl) | 9.66 | 9.81 | 11.25 | <0.0001b |
Platelet Count (109/l) | 178.33 | 249.88 | 275.14 | <0.0001b |
Continuous variables presented as mean values and categorical variables are represented as integers
Statistically significant at P<0.05. BMI, body-mass index; ACE-27, adult comorbidity evaluation 27 score; ECOG, Eastern Cooperative Oncology Group score; WBC, white blood cell count; MPV, mean platelet volume; COP-MPV, combination of platelet count and mean platelet volume score.